Trial intelligence / Profile preview

Bupivacaine Irrigation for Postoperative Pain in Third Molar Extraction

NCT03950700Phase 4Completed

Sponsor
Universidad CES
Start
Jun 2019
Primary completion
Dec 2019
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of bupivacaine in postoperative pain, sponsored by Universidad CES. Started Jun 2019; status: completed.

02

Drugs

bupivacaine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT03950700.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03950700.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call